Target intelligence / Profile preview

Caveolin-1 mRNA 3' untranslated region (CAV1 mRNA 3' UTR) (CAV1 mRNA 3' UTR)

Target
CAV1 mRNA 3' UTR
Molecular classification
RNA, Untranslated region, Regulatory RNA element
01

Overview

The Caveolin-1 (CAV1) mRNA 3' untranslated region (3' UTR) is a critical regulatory segment of the CAV1 transcript that governs the stability and translational efficiency of the Caveolin-1 protein. Caveolin-1 is the principal structural component of caveolae, specialized plasma membrane invaginations involved in endocytosis, cholesterol homeostasis, and the regulation of various signaling pathways, including Src and Ras (UniProt P33176). The 3' UTR contains multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins, such as miR-103, miR-107, and miR-204, which modulate CAV1 expression in response to cellular stress and environmental cues (Trajkovski et al., 2011; PubMed: 21654804). Dysregulation of the CAV1 3' UTR-mediated control is implicated in several pathologies; for instance, its downregulation is linked to pulmonary fibrosis and certain aggressive cancers, while its overexpression can promote metastasis in other contexts (PubMed: 22508264). Consequently, the CAV1 3' UTR is an emerging therapeutic target for RNA-based interventions, such as miRNA mimics or antisense oligonucleotides, aimed at restoring homeostatic Caveolin-1 levels in disease states.

Other names
CAV1 3' UTRCaveolin-1 3-prime untranslated regionCAV1 mRNA 3-prime UTR
02

Mechanism of action

Modulation of protein expression through RNA interference or steric hindrance of regulatory element binding

03

Biological functions

Regulation of mRNA stabilityRegulation of translationmiRNA bindingPost-transcriptional regulation
04

Disease associations

CancerPulmonary fibrosisCardiovascular diseaseMetabolic syndromeInsulin resistance
05

Safety considerations

Context-dependent role of CAV1 in cancer (tumor suppressor vs. oncogene)Off-target effects of RNA-based therapeuticsPotential for systemic toxicity from delivery vehicles
06

Interacting drugs

miR-103/107 antagomirs (experimental)

2 more in the full profile.

07

Biomarkers

CAV1 protein expressionmiR-103 levelsmiR-107 levelsmiR-204 levels

Beyond the preview

Go deeper on Caveolin-1 mRNA 3' untranslated region (CAV1 mRNA 3' UTR) (CAV1 mRNA 3' UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Caveolin-1 mRNA 3' untranslated region (CAV1 mRNA 3' UTR) (CAV1 mRNA 3' UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call